Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation
NCT00219635
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
138
Enrollment
INDUSTRY
Sponsor class
Conditions
Ejaculation
Interventions
DRUG:
UK-390,957
Sponsor
Pfizer